This document summarises evidence from studies included in the licensing file of HPV vaccines together with postlicensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV vaccines observed during the pre- and post-licensing period.
This guide presents the reader with a host of ideas on how to effectively communicate on all issues that relate to measles, mumps and rubella (MMR) vaccination.